4 results
Not approvedWill not start
The aim of this study is determine the efficacy and safety of Metformin as a weight reducing drug in the euglykemic, obese paediatric population.
Approved WMOWill not start
Primary objectiveTo confirm the superiority of liraglutide at the maximum tolerated dose (0.6 mg, 1.2 mg or 1.8 mg) versus placebo when added to metformin with or without basal insulin treatment in controlling glycaemia in children and adolescents (…
Approved WMOCompleted
To test the safety and feasibility of a closed loop controller of the FiO2 based on the measured SpO2 in a NICU setting.
Approved WMORecruiting
To assess safety and efficacy of AMX0035 for treatment of ALS.